The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106. (Record no. 19432891)

MARC details
000 -LEADER
fixed length control field 02208 a2200637 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515202559.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201003s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1538-8514
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1158/1535-7163.MCT-09-0938
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Walton, Michael I
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20100322
245 00 - TITLE STATEMENT
Title The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Molecular cancer therapeutics
Date of publication, distribution, etc. Jan 2010
300 ## - PHYSICAL DESCRIPTION
Extent 89-100 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers, Tumor
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Camptothecin
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Death
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cell Line, Tumor
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Checkpoint Kinase 1
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element DNA Damage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Deoxycytidine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Synergism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element G2 Phase
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Irinotecan
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Isoquinolines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice, Nude
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mutagens
General subdivision toxicity
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Phosphorylation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinase Inhibitors
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Protein Kinases
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrazines
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Xenograft Model Antitumor Assays
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gemcitabine
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eve, Paul D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hayes, Angela
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Valenti, Melanie
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name De Haven Brandon, Alexis
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Box, Gary
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Boxall, Kathy J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Aherne, G Wynne
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Eccles, Suzanne A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Raynaud, Florence I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Williams, David H
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Reader, John C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Collins, Ian
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garrett, Michelle D
773 0# - HOST ITEM ENTRY
Title Molecular cancer therapeutics
Related parts vol. 9
-- no. 1
-- p. 89-100
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1158/1535-7163.MCT-09-0938">https://doi.org/10.1158/1535-7163.MCT-09-0938</a>
Public note Available from publisher's website

No items available.